EP3370756
Samsetning kanrenóats og exenatíðs
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.11.2016EP published:
8.4.2020EP application number:
16802132.7
EP translation filed:
26.5.2020Grant published:
15.6.2020EPO information:
European Patent Register
Max expiry date:
3.11.2036Expiry date:
3.11.2026Next due date:
30.11.2026
Title:
COMBINATION OF CANRENOATE AND EXENATIDE
Timeline
Today
4.11.2016EP application
8.4.2020EP Publication
26.5.2020Translation submitted
15.6.2020Registration published
3.11.2026Expires
Owner
Name:
Genesis Pharma SAAddress:
270 Kifissias Avenue, 15232 Athens, GR
Inventor
Name:
VOGIATZIS, GeorgeAddress:
15232 Athens, GR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
20150100486Date:
6.11.2015Country:
GR
Classification
Categories:
A61K 38/13, A61K 38/26, A61P 9/10
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 24.11.2020
Expires: 3.11.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 24.11.2021
Expires: 3.11.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 22.11.2022
Expires: 3.11.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 22.12.2023
Expires: 3.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 25.11.2024
Expires: 3.11.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 28.11.2025
Expires: 3.11.2026
Payer: Árnason Faktor ehf.